- 115 utilisateurs
-
View this email in your browser WORLD IMMUNIZATION WEEK 2024 CELEBRATE WORLD IMMUNIZATION WEEK WITH IVAC: REGISTER NOW! When: Thursday, April 25, from 11am–12pm ET Description: As part of World Immunization Week 2024, the International Vaccine Access Center (IVAC) at the Johns Hopkins Bloomberg School of Public He...Publication en cours de modérationStatut publié avec succès. Il est désormais visible dans votre journal.
-
Dates: 14-16 November 2023 Participants: Virtually all countries and territories that had submitted annual reports for the period 2021-2023 participated for the Regional Commission's review and face-to-face interaction with the presidents of the sustainability committees and responsible for epidemiological surveillance, laboratory and i...Publication en cours de modérationStatut publié avec succès. Il est désormais visible dans votre journal.
-
Dates: 14-16 November 2023 Participants: Virtually all countries and territories that had submitted annual reports for the period 2021-2023 participated for the Regional Commission's review and face-to-face interaction with the presidents of the sustainability committees and responsible for epidemiological surveillance, laboratory and i...Publication en cours de modérationStatut publié avec succès. Il est désormais visible dans votre journal.
-
Dates: 12-13 December 2023 More than 120 participants attended this annual hybrid WHO meeting, with global, regional and country level representation of public health and immunization stakeholders, technical experts and vaccine product developers and manufacturers. The Product Development for Vaccines Advisory Committee (PDVAC) provides...Publication en cours de modérationStatut publié avec succès. Il est désormais visible dans votre journal.
-
Dates: 27/02/2024 Participants: 622 participants, representing 49 countries from the Americas, Europe, Africa, Western Pacific and Southeast Asia WHO world regions. The meeting was attended by authorities and technical teams from Expanded Programs on Immunization (EPI) and Health Systems in Ministries of Health, PAHO’s immunizatio...Publication en cours de modérationStatut publié avec succès. Il est désormais visible dans votre journal.
-
Dates: 27/02/2024 Participants: 622 participants, representing 49 countries from the Americas, Europe, Africa, Western Pacific and Southeast Asia WHO world regions. The meeting was attended by authorities and technical teams from Expanded Programs on Immunization (EPI) and Health Systems in Ministries of Health, PAHO’s immunizatio...Publication en cours de modérationStatut publié avec succès. Il est désormais visible dans votre journal.
-
Dates: 17-28 July 2023 Participants: There was a total of 36 participants, including: 11 PAHO/WHO headquarters staff, 6 PAHO/WHO immunization focal points from Argentina, English Caribbean, Costa Rica, Panama, Peru, and Suriname, 8 international consultants for immunizations and 11 health personnel from Peru. Background: PAH...Publication en cours de modérationStatut publié avec succès. Il est désormais visible dans votre journal.
-
INFUSE 2024 call for innovations
Gavi is proud to announce that INFUSE 2024 is actively seeking innovative solutions uniquely positioned to enhance health systems, enabling them to effectively manage resilient and climate-adaptive responses to climate threats.
***
Gavi, the Vaccine Alliance, in partnership with Seedstars, announces INFUSE 2024: a global call for applications for innovations to bolster health systems against climate threats and to enhance immunisation delivery.
Innovation for Uptake, Scale and Equity in Immunisation, or INFUSE, aims to scale up groundbreaking global health solutions by connecting high-impact, proven innovations where countries need them most.
This year’s INFUSE initiative underscores the urgency of addressing health challenges exacerbated by climate change, including increased vulnerability to diseases sensitive to climate conditions – such as malaria – and the likelihood of more frequent and severe disease outbreaks due to extreme weather.
…INFUSE 2024 call for innovations
Gavi is proud to announce that INFUSE 2024 is actively seeking innovative solutions uniquely positioned to enhance health systems, enabling them to effectively manage resilient and climate-adaptive responses to climate threats.
***
Gavi, the Vaccine Alliance, in partnership with Seedstars, announces INFUSE 2024: a global call for applications for innovations to bolster health systems against climate threats and to enhance immunisation delivery.
Innovation for Uptake, Scale and Equity in Immunisation, or INFUSE, aims to scale up groundbreaking global health solutions by connecting high-impact, proven innovations where countries need them most.
This year’s INFUSE initiative underscores the urgency of addressing health challenges exacerbated by climate change, including increased vulnerability to diseases sensitive to climate conditions – such as malaria – and the likelihood of more frequent and severe disease outbreaks due to extreme weather.
The programme aims to select and scale innovations that contribute to low-carbon and sustainable, resilient health care systems; enhance frontline health workers’ capacity to manage climate-related health threats; and ensure efficient vaccine distribution under challenging climate conditions. Examples of projects supported by INFUSE in the past :
- To prevent vaccine damage from excessive heat or cold, Nexleaf Analytics and Parsyl are deploying state-of-the-art sensor technology.
- To help Pakistan and Mozambique reach under-immunised children, Zenysis Technologies is harnessing big data analytics to sharpen the accuracy of vaccine planning.
- To ensure that every child is registered in the health system and receives critical vaccines, Simprints is pioneering biometrics in Bangladesh, Ghana and Tanzania.
Augustin Flory, Managing Director, Innovative Partnerships & Development Finance at Gavi, said: “The climate crisis has significant implications for vaccine-preventable diseases and immunisation programmes. INFUSE is a great platform to mobilise the latest innovations in support of the health community to drive adaptive and mitigative actions against climate change.”
Sheilla Atieno, Seedstars Program Manager Africa, highlighted the importance of this initiative: “Our collaboration with Gavi for INFUSE 2024 is crucial in our fight against the health impacts of climate change. We are calling on innovators globally to come forward with solutions that can make a tangible difference in building climate-resilient health systems.”
The open call for INFUSE 2024 invites applications that demonstrate innovative approaches to tackle challenges faced by Gavi implementing countries and their partners, focusing on climate mitigation and resilience. The criteria for participation include scalability and potential impact in vulnerable regions; cost-effectiveness with a sustainable financial model; evidence of or potential for success; adaptability for implementation in diverse environments, especially in lower-income countries; and the strength and experience of the team behind the solution.
Innovators and startups across the globe, particularly from lower-income countries, are encouraged to apply for this opportunity. Selected innovations will be part of the INFUSE community, receiving focused support to scale their solutions globally.
Calling all innovators! Learn more and apply here: https://www.gavi.org/investing-gavi/infuse/call-innovations/infuse-2024-call-innovations
Application deadline: 11:59 pm (23:59) CEST (Geneva time) on 14 April 2024
Publication en cours de modérationStatut publié avec succès. Il est désormais visible dans votre journal. - To prevent vaccine damage from excessive heat or cold, Nexleaf Analytics and Parsyl are deploying state-of-the-art sensor technology.
-
Publication en cours de modérationStatut publié avec succès. Il est désormais visible dans votre journal.
-
IVAC at ISPPD 2024 Several IVAC projects will be represented at ISPPD 2024 through a number of posters and oral presentations. We look forward to connecting with colleagues over the next several days. Plenary Session 01: Equity in Pneumonia Prevention and Treatment Monday, 18 March, 09:05–10:35, Ballroom East Co-chaired by Dr. L...Publication en cours de modérationStatut publié avec succès. Il est désormais visible dans votre journal.
-
Publication en cours de modérationStatut publié avec succès. Il est désormais visible dans votre journal.
-
The HISP Centre at University of Oslo invites you to join us for the next edition in our Gavi-supported DHIS2 for Immunization webinar series. This quarter, our focus is on DHIS2 use in immunization supply chains. We will present examples from the Unicef-Thrive360 National Control tower project in Nigeria and Sierra Leone, which illustrate how how stock dashboards can support decision making and reporting. Additionally, we will share examples from various countries of existing stock data that is already captured in HMIS (DHIS2) instances can be used through similiar initiatives to improve the supply of medicines.
This webinar will be hosted in both English and French:
- English: Tuesday 19 March, 14:00 – 15:00 CET - Registration
- French: Thursday 21 March, 14:00 – 15:00 CET - Registration
We hope you join us for this online event.
Publication en cours de modérationStatut publié avec succès. Il est désormais visible dans votre journal. -
Start date: 28 November 2023Termination Date: 30 November 2023 Participants: Immunization Services Division (IVD/CDC), Department of Information Systems and Directorate of Integrated Health Networks (DIRIS), Lima East, San Marcos, and Alpha Omega health facilities, as well as the Special Program for Comprehensive Immunization (CIM) and Peru co...Publication en cours de modérationStatut publié avec succès. Il est désormais visible dans votre journal.
-
Vaccination and deworming are interventions of proven benefit to improve the well-being of the population and reduce health gaps, so strategies should be sought to guarantee effective access and ensure systematic monitoring and analysis of their coverage. The Special Program for Integrated Immunization (CIM) together with the Unit for Neglected Tro...Publication en cours de modérationStatut publié avec succès. Il est désormais visible dans votre journal.
-
Vaccination and deworming are interventions of proven benefit to improve the well-being of the population and reduce health gaps, so strategies should be sought to guarantee effective access and ensure systematic monitoring and analysis of their coverage. The Special Program for Integrated Immunization (CIM) together with the Unit for Neglected Tro...Publication en cours de modérationStatut publié avec succès. Il est désormais visible dans votre journal.